These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 24685201)

  • 21. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid.
    Travis WD; Rush W; Flieder DB; Falk R; Fleming MV; Gal AA; Koss MN
    Am J Surg Pathol; 1998 Aug; 22(8):934-44. PubMed ID: 9706973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Symptoms and diagnostics of lung neuroendocrine tumors].
    Tamási L; Müller V
    Orv Hetil; 2011 Mar; 152(10):366-70. PubMed ID: 21354952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects.
    Neubauer E; Wirtz RM; Kaemmerer D; Athelogou M; Schmidt L; Sänger J; Lupp A
    Oncotarget; 2016 Jul; 7(27):41959-41973. PubMed ID: 27259241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. hASH1 is a specific immunohistochemical marker for lung neuroendocrine tumors.
    Ye B; Cappel J; Findeis-Hosey J; McMahon L; Yang Q; Xiao GQ; Xu H; Li F
    Hum Pathol; 2016 Feb; 48():142-7. PubMed ID: 26596584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical treatment of neuroendocrine tumors of the lung.
    Daddi N; Ferolla P; Urbani M; Semeraro A; Avenia N; Ribacchi R; Puma F; Daddi G
    Eur J Cardiothorac Surg; 2004 Oct; 26(4):813-7. PubMed ID: 15450578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin receptors in bronchopulmonary neuroendocrine neoplasms: new diagnostic, prognostic, and therapeutic markers.
    Kaemmerer D; Specht E; Sänger J; Wirtz RM; Sayeg M; Schulz S; Lupp A
    J Clin Endocrinol Metab; 2015 Mar; 100(3):831-40. PubMed ID: 25494861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of pulmonary neuroendocrine tumors.
    Ramirez RA; Chauhan A; Gimenez J; Thomas KEH; Kokodis I; Voros BA
    Rev Endocr Metab Disord; 2017 Dec; 18(4):433-442. PubMed ID: 28868578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated PET/CT of pulmonary neuroendocrine tumors: diagnostic and prognostic implications.
    Chong S; Lee KS; Kim BT; Choi JY; Yi CA; Chung MJ; Oh DK; Lee JY
    AJR Am J Roentgenol; 2007 May; 188(5):1223-31. PubMed ID: 17449764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulmonary neuroendocrine tumors: an entity in search of cytologic criteria.
    Huang CC; Collins BT; Flint A; Michael CW
    Diagn Cytopathol; 2013 Aug; 41(8):689-96. PubMed ID: 23166111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of pulmonary neuroendocrine tumours: state of the art and future developments.
    Gridelli C; Rossi A; Airoma G; Bianco R; Costanzo R; Daniele B; Chiara GD; Grimaldi G; Irtelli L; Maione P; Morabito A; Piantedosi FV; Riccardi F
    Cancer Treat Rev; 2013 Aug; 39(5):466-72. PubMed ID: 22818212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung.
    Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M
    Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical presentation and evaluation of neuroendocrine tumors of the lung.
    Detterbeck FC
    Thorac Surg Clin; 2014 Aug; 24(3):267-76. PubMed ID: 25065927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pulmonary neuroendocrine tumors and preneoplasic lesions].
    Rouquette Lassalle I
    Ann Pathol; 2016 Jan; 36(1):34-43. PubMed ID: 26776366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectrum of pulmonary neuroendocrine proliferations and neoplasms.
    Benson RE; Rosado-de-Christenson ML; Martínez-Jiménez S; Kunin JR; Pettavel PP
    Radiographics; 2013 Oct; 33(6):1631-49. PubMed ID: 24108555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroendocrine tumours--challenges in the diagnosis and classification of pulmonary neuroendocrine tumours.
    den Bakker MA; Thunnissen FB
    J Clin Pathol; 2013 Oct; 66(10):862-9. PubMed ID: 23685279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?
    Pelosi G; Fabbri A; Cossa M; Sonzogni A; Valeri B; Righi L; Papotti M
    Semin Diagn Pathol; 2015 Nov; 32(6):469-79. PubMed ID: 26561395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative proteomics of pulmonary tumors with neuroendocrine differentiation.
    Cho NH; Koh ES; Lee DW; Kim H; Choi YP; Cho SH; Kim DS
    J Proteome Res; 2006 Mar; 5(3):643-50. PubMed ID: 16512680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary neuroendocrine/carcinoid tumors: a review article.
    Bertino EM; Confer PD; Colonna JE; Ross P; Otterson GA
    Cancer; 2009 Oct; 115(19):4434-41. PubMed ID: 19562772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroendocrine tumors of the lung: A five-year retrospective experience of Egyptian NCI (2010-2014).
    Saber M; Ismail Y; Alieldin N; Loay I; El Zawahry M
    J Egypt Natl Canc Inst; 2018 Dec; 30(4):151-158. PubMed ID: 30470605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary carcinoid and related tumours.
    Hasleton PS; Bostanci G
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():28-42. PubMed ID: 9337521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.